GlassScriptPhysician profile
Dwight Julius Korgan
NPI 1235102146
$1,698.60
in general payments reported to CMS, 2019-2025
20 companies · $62.86 in 2025
The $62.86 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $243 · 2021: $371 · 2022: $265 · 2023: $148 · 2024: $304 · 2025: $62.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $361.35 | 2019-2024 | Rybelsus |
| Astrazeneca Pharmaceuticals LP | $305.80 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.33 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $127.02 | 2019-2024 | Jardiance, Mounjaro |
| Abbvie INC. | $118.69 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $104.54 | 2021-2024 | Rexulti |
| Pfizer INC. | $90.40 | 2020-2021 | |
| Amgen INC. | $79.12 | 2019-2021 | |
| Allergan, INC. | $58.58 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $53.20 | 2024 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.99 | 2024-2025 | Caplyta |
| Edwards Lifesciences Corporation | $39.04 | 2024 | |
| Janssen Pharmaceuticals, INC | $36.72 | 2019-2024 | Spravato |
| Glaxosmithkline, LLC. | $35.74 | 2020-2024 | Trelegy Ellipta |
| Alnylam Pharmaceuticals INC. | $24.82 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $19.34 | 2022 | |
| Vivus LLC | $17.89 | 2024 | Qsymia |
| Sanofi Pasteur INC. | $16.01 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.54 | 2020 | |
| Lundbeck LLC | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Korgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.